nach oben

Drugs

Erschienen in:

17.03.2023 | Letter to the Editor

Comment on: “Risk of Erectile Dysfunction in Male Patients with Gout Treated with Febuxostat or Allopurinol: A Propensity Score-Matched Cohort Study”

verfasst von: Jin-Xian Huang, Guo-Wen Zhang

Erschienen in: Drugs | Ausgabe 5/2023

Einloggen, um Zugang zu erhalten

Excerpt

Dear Editors …

Tong Q, Du Y, Cui R, et al. Risk of erectile dysfunction in male patients with gout treated with febuxostat or allopurinol: a propensity score-matched cohort study. Drugs. 2022;82(18):1717–26.CrossRefPubMed

FitzGerald JD, Dalbeth N, Mikuls T, et al. 2020 American College of Rheumatology Guideline for the management of gout. Arthritis Rheumatol. 2020;72(6):879–95.CrossRefPubMed

Lorenzo JPP, Sollano MHMZ, Salido EO, et al. 2021 Asia-Pacific League of Associations for Rheumatology clinical practice guideline for treatment of gout. Int J Rheum Dis. 2022;25(1):7–20.CrossRefPubMed

Liu KL, Ye LL, Chou SH, et al. Erectile dysfunction is not a predictor of atrial fibrillation: a population-based propensity-score matched cohort study. J Sex Med. 2016;13(1):55–62.CrossRefPubMed

Schlesinger N, Lu N, Choi HK. Gout and the risk of incident erectile dysfunction: a body mass index-matched population-based study. J Rheumatol. 2018;45(8):1192–7.CrossRefPubMed

Chu KY, Nackeeran S, Horodyski L, et al. COVID-19 infection is associated with new onset erectile dysfunction: insights from a National Registry. Sex Med. 2022;10(1): 100478.CrossRefPubMed

Chen YF, Lin HH, Lu CC, et al. Gout and a subsequent increased risk of erectile dysfunction in men aged 64 and under: a nationwide cohort study in Taiwan. J Rheumatol. 2015;42(10):1898–905.CrossRefPubMed

Mazzilli F. Erectile dysfunction: causes, diagnosis and treatment: an update. J Clin Med. 2022;11(21):6429.CrossRefPubMedPubMedCentral

Nackeeran S, Havanur A, Ory J, et al. Erectile dysfunction is a modifiable risk factor for major depressive disorder: analysis of a federated research network. J Sex Med. 2021;18(12):2005–11.CrossRefPubMed

10.

Saltzman RG, Golan R, Masterson TA 3rd, et al. Restorative therapy clinical trials for erectile dysfunction: a scoping review of endpoint measures. Int J Impot Res. 2022. https://doi.org/10.1038/s41443-022-00610-3.

11.

Goberdhan S, Blachman-Braun R, Nackeeran S, et al. Is tadalafil associated with decreased risk of major adverse cardiac events or venous thromboembolism in men with lower urinary tract symptoms? World J Urol. 2022;40(7):1799–803.CrossRefPubMedPubMedCentral

12.

Tuokko AT, Murtola T, Korhonen P, et al. Hyperuricemia is not an independent predictor of erectile dysfunction. Sex Med. 2021;9(2): 100319.CrossRefPubMedPubMedCentral

13.

Totaro M, Dimarakis S, Castellini C, et al. Erectile dysfunction in hyperuricemia: a prevalence meta-analysis and meta-regression study. Andrology. 2022;10(1):72–81.CrossRefPubMed

14.

Chou HW, Chiu HT, Tsai CW, et al. Comparative effectiveness of allopurinol, febuxostat and benzbromarone on renal function in chronic kidney disease patients with hyperuricemia: a 13-year inception cohort study. Nephrol Dial Transplant. 2018;33(9):1620–7.PubMed

15.

Neilson J, Bonnon A, Dickson A, et al. Gout: diagnosis and management-summary of NICE guidance. BMJ. 2022;378: o1754.CrossRefPubMed

16.

Agrawal P, Singh SM, Able C, et al. Sleep disorders are associated with testosterone deficiency and erectile dysfunction-a U.S. claims database analysis. Int J Impot Res. 2022. https://doi.org/10.1038/s41443-022-00649-2.

17.

Agrawal P, Singh SM, Kohn J, et al. Sleep disorders are associated with female sexual desire and genital response—a U.S. claims database analysis. Urology. 2023:172:79–83. https://doi.org/10.1016/j.urology.2022.11.017.

18.

Cantone E, Massanova M, Crocetto F, et al. The relationship between obstructive sleep apnoea and erectile dysfunction: an underdiagnosed link? A prospective cross-sectional study. Andrologia. 2022;54(9): e14504.CrossRefPubMedPubMedCentral

19.

Colbourne L, Harrison PJ. Brain-penetrant calcium channel blockers are associated with a reduced incidence of neuropsychiatric disorders. Mol Psychiatry. 2022;27(9):3904–12.CrossRefPubMedPubMedCentral

20.

Chung SD, Liu JC, Lou TN, et al. Relation between mitral valve prolapse and erectile dysfunction (from a nationwide case-control study). Am J Cardiol. 2019;124(10):1590–3.CrossRefPubMed

Titel: Comment on: “Risk of Erectile Dysfunction in Male Patients with Gout Treated with Febuxostat or Allopurinol: A Propensity Score-Matched Cohort Study”
verfasst von: Jin-Xian Huang
Guo-Wen Zhang
Publikationsdatum: 17.03.2023
Verlag: Springer International Publishing
Erschienen in: Drugs / Ausgabe 5/2023
Print ISSN: 0012-6667
Elektronische ISSN: 1179-1950
DOI: https://doi.org/10.1007/s40265-023-01849-w

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2023

Emerging Therapies for Chronic Hepatitis B and the Potential for a Functional Cure

Ublituximab: First Approval

A Review of RRx-001: A Late-Stage Multi-Indication Inhibitor of NLRP3 Activation and Chronic Inflammation

Bexagliflozin: First Approval

Teplizumab: First Approval

Aspirin for the Prevention of Early and Severe Pre-Eclampsia Recurrence: A Real-World Population-Based Study